Merck KGaA Boss Planning A New Round of Smaller Deals

Merck KGaA Boss Planning A New Round of Smaller Deals

By John Carroll Don’t expect Merck KGaA to announce any big takeover deals this year. But everything else is on the table, including licensing pacts, R&D alliances and small buyouts. That’s the word from Chief Executive Karl-Ludwig Kley, who says his primary task this year will be the absorption of Millipore. After that the company …

Merck KGaA: Millipore Buy ‘Worth Every Euro’

By Liz Jones Merck KGaA’s $6 billion purchase of Massachusetts-based biotechnology equipment supplier Millipore is “worth every euro,” CEO Karl-Ludwig Kley told shareholders at his company’s annual general meeting today. In February, the German drugmaker , beating out Thermo Fisher. Including debt, the deal is valued at $7.2 billion. “In the days after the Feb. 28 …